Seely Lynn bought LYEL
October 27, 2025 · Form 4 insider transaction
Seely Lynn bought 175,000 shares of Lyell Immunopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
175,000
Price
$0.00
Total value
N/A
InsiderSeely Lynn
RoleOfficer, Director
SecurityOption (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 27, 2025
Filing dateOctober 29, 2025
Shares owned after175,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
12.5% of the option shares will vest on April 27, 2026, with the remaining option shares to vest in equal monthly installments over the following forty-two months, subject to the reporting person providing service through the applicable vesting date.